05-11-2011 22:38 Dr. Jay Lombard discusses scientific, clinical, and research aspects regarding the pharmacodynamic and pharmacokinetic genes in the Genecept™ Assay - genes that influence neurotransmitter activity and treatment plans for neuropsychiatric disorders. He also talks about recent developments in the science of biomarkers for dopamine and serotonin, as well as genes that affect drug metabolism in the body
Read more:
Personalized Medicine and the Science Behind the Genomind Genecept Assay - Video